
T-DXd’s Robust Efficacy and Response Continue in Frontline MBC
Fabrice André, MD, PhD Professor of Medicine University of Paris-Saclay Director, Division of Research Breast Cancer Unit Professor, Department of Medical Oncology Institut Gustave Roussy Villejuif, France Both trastuzumab deruxtecan (T-DXd; Enhertu) …